Changing the way we see the gut

Dynamic or 'cine' MRI offers a new and potentially powerful perspective on gastrointestinal function, especially in conditions like Crohn's where hypo-motility is related to disease activity. Objective assessment of this data with GIQuant could represent an important advance in how we quantify this in the clinic.

Professor Stuart Taylor - Consultant Radiologist, University College London

A fantastic, purpose built platform multi-rater scoring and mark-up of IBD imaging…

Jonathan Dillman - Pediatric Radiologist at Cincinnati Children's Hospital

Entrolytics is the only product I've found which excels at state-of-the-art IBD reporting, and multi-centre clinical research. It has the potential to help me deliver objective insights, as opposed to opinion alone, to my gastroenterologists and surgeons, without adding to the burden of my existing caseload. I am desperate to get it into use in my clinical workstream.

Dr Gauraang Bhatnagar - Employee of Motilent, and an Academic and Clinical Radiologist in Surrey, UK

STMM is a great tool as it provides rich information about the size and coordination of contractions in the stomach and colon without having to use invasive probes

Heather Fitzke - MSc PhD University College London

We enjoy using the Entrolytics platform for our interventional studies on small bowel motility using MRI. The analysis is straightforward with access to both simple and more advanced tools.

Esben Bolvig Mark - Postdoc researcher at Aalborg University Hospital, Denmark

We now have a lot of therapies for patients with Crohn's Disease. What is lacking is the tests to match the patient with the best treatment for them. GIQuant is a new tool for small bowel Crohn's based on MRI and I get a simple, objective score for a small bowel lesion helping me track treatment response. We're now about to start testing this technology across the NHS but non-invasive, objective and widely available tools like GIQuant are crucial to managing growing budgets and improving patient outcomes.

It’s like a PACS but for Endoscopy, and on the web.

Dr Gordon Moran - University of Nottingham Associate Professor Consultant Gastroenterologist

I have used the Entrolytics platform in my research trials and it has been indispensable. Gone are the days of DICOM email attachments, measurements recorded in spreadsheets (without being able to trace them back to the original imaging), and incompatible PACS with missing features. Entrolytics is the future of auditable, high-quality research.

Dr Harbir Sidhu - Consultant Radiologist at UCLH